Glass polyalkenoate cements (GPCs) are acid base cements formed by the reaction of an aqueous solution of polyalkenoic acid, usually polyacrylic acid (PAA) with an acid degradable aluminosilicate glass. The result of the reaction is cement consisting of reacted and unreacted glass particles embedded in a polysalt matrix. In addition to these conventional GPCs, aluminium free glass polyalkenoate cements based on zinc silicate glasses (Zn-GPCs) exhibit significant potential as bone cements for several reasons. Primarily, they are formulated without the inclusion of aluminium (Al) [1] in the glass phase and thus eliminate clinical complications arising from the release of the Al 3+ ion from the cement in vivo. Such complications have, in the past, included aluminium induced encephalopathy [2] [3] [4] [5] and defective mineralisation of cancellous bone [6] . Secondly, Zn-GPCs set without a significant evolution of heat, when compared with commercial bone cements such as Spineplex ® (Stryker, Limerick, Ireland). Finally, these materials can be tailored to release clinically beneficial ions into surrounding tissues [7] . In addition to Zn, these cements have been synthesized to contain strontium (Sr) [8, 9] . Both Sr and Zn inhibit osteoclastic turnover and promote osteoblastic turnover, resulting in increased bone strength and decreased fracture risk [10] [11] [12] [13] [14] .
Conventional GPCs bond directly to hydroxyapatite (HA) the mineral phase of tooth and bone, via the adsorption of carboxylate groups of the polyacid chains into the HA structure [15] . This indicates all conventional GPCs are capable of bonding to living bone. However, it has been postulated that an essential requirement for a material to bond to living bone lay in its ability to form a bone like crystalline apatite layer at its surface in vivo and that such a system can be replicated using simulated body fluid (SBF) [16] . Kamitakahara et al. recently used SBF to evaluate the bone bonding ability of conventional GPCs and found that PAA inhibited the formation of an apatite layer at the surface of GPCs and thus concluded that they were unlikely to bond to bone in vivo [17] .
Given these conflicting viewpoints, the authors have previously evaluated the ability of Zn-GPCs to form a bone like apatite layer in vitro using SBF [1, 9] . It was shown that calcium phosphate layers are produced on Zn-GPCs immersed in SBF within 24 hours. However, thin film x-ray diffraction (TF-XRD) indicates no crystallinity within the surface layer, and chemical analysis using scanning electron microscopy (SEM) and energy dispersive x-ray spectroscopy (EDS) of the surface layers is complicated by the collection of elemental signatures from the cement sample itself.
In order to eliminate these issues, this letter seeks to validate the amorphous nature and composition of the surface layers observed on Zn-GPCs after immersion in SBF using transmission electron microscopy.
One glass composition 0.08SrO / 0.08CaO / 0.36ZnO / 0.48 SiO 2 (mol. fraction), was synthesized. Appropriate amounts of analytical grade strontium carbonate, calcium carbonate, zinc oxide and silicon dioxide (Sigma Aldrich, Dublin, Ireland), were weighed out in a plastic tub and mixed in a ball mill for one hour, then dried (100°C, 1Hr). The pre-fired glass batch was then transferred to a platinum crucible for firing (1480°C, 1Hr). The glass melt was subsequently quenched into water and the resulting frit was dried, ground and sieved to retrieve a <45µm glass powder. The glass was then annealed (645°C, 3h) for subsequent use in Zn-GPC specimen preparation.
One Zn-GPC (termed BT102) was prepared by mixing the glass with a 50wt% aqueous solution of PAA; M w = 80,800 (Advanced Healthcare, UK) on a clean glass slab with a dental spatula at a powder liquid ratio of 2:1.5.
SBF was produced in accordance with the literature [16] . The composition is illustrated in Table 2 . Reagents were dissolved in sequential order (as per Table 2) into 500ml of purified water (Reagecon, Shannon, Ireland) using a magnetic stirrer.
The solution was maintained at 36.5°C (±1.5°C) using a water bath. 1 M -HCL was titrated to adjust the pH of the SBF to 7.40. Purified water was then added to adjust the total volume of liquid to one litre. Once prepared, the SBF was stored for 24 hours (5°C) to ensure that no precipitation occurred.
INSERT TABLE 1 HERE
BT102 (n=3, per incubation period) was prepared as described previously.
Each specimen of cement was subsequently immersed in a volume of SBF such that the following equation was satisfied:
V s = S a /10 …Equation 2
Where:
V s is the volume of SBF (ml).
S a is the surface area of the specimen (mm 2 ).
Specimens were stored in plastic containers for 30 and 90 days. After the specified incubation times, the cements were removed from the SBF, gently rinsed in deionised water, placed on individually labelled sheets of filter paper and oven dried (37 °C, 24 h). The rationale for the prolonged periods of immersion of BT102 in SBF was twofold. In the first instance, prolonged immersion ensured the development of a thick dense surface layer, such that TEM samples could be readily obtained.
Secondly, it was contended that increased immersion time over conventional procedures may facilitate crystallisation of the surface layer.
TEM analysis indicated a porous type structure, typified by the image shown in Figure 1a and 2. Selected area diffraction analysis indicated an amorphous structure as indicated in Figure 1b . The results indicated in Figure 1 and 2 were found to be representative of the sample as a whole, after a number of different areas were analysed and varying selected area diffraction apertures used to record the diffraction pattern.
The compositional elements of the surface layer, as identified by EDS ( Figure   3 ) indicate the presence of calcium (Ca), phosphorus (P), zinc (Zn) and strontium (Sr)
within the amorphous structure, with the presence of copper (Cu) owing to the Cugrid on which the sample is placed for analysis. Critically, this composition, in particular the inclusion of Zn in the structure, explicates the lack of crystallinity associated with the formation of the apatite layers observed on Zn-GPCs after immersion in SBF [1, 9] . Zn-GPCs release clinically beneficial amounts of Zn 2+ from the mantle of set cements for prolonged periods of time to inhibit bacterial colonization of the implant [7] . However, literature shows that Zn is effective at inhibiting the crystallisation of HA [18] ; one report states that Zn is 1000 times more effective at inhibiting the crystallization kinetics of hydroxyapatite than magnesium (Mg) [19] . As such the release of Zn 2+ and its subsequent inclusion in the apatite layer favours the formation of amorphous apatite (Figures 1 and 2) , as opposed to the deposition of crystalline apatite on conventional GPCs examined under simulated in vivo conditions [20] . However, the presence of such an amorphous layer is comparable to the biological formation of HA in vivo, where prior to the formation of crystalline apatite, the predominant precursor has been cited as amorphous calcium phosphate (ACP) [21] . The ability of Zn-GPCs to produce amorphous apatite layer in vivo is related to zinc release and its subsequent uptake by the precipitating apatite layer. The apatite layer observed in this work is similar to that contended to occur in the natural mineralisation process in bone [21] and indicates that these materials will likely bond directly to living bone tissue [16] .
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